M3 (TSE:2413) Cyclically Adjusted Revenue per Share: 円303.69 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSE:2413 M3 Inc TSE:2413
82 GF Score
Price 円1,735.00
GF Value 円2,520.72
Valuation Significantly Undervalued
! 3 Warning Signs
View Full Analysis

What is M3 Cyclically Adjusted Revenue per Share?

M3 TSE:2413 -1.95% 82 Cyclically Adjusted Revenue per Share is 円303.69 as of Mar. 2026. GuruFocus rates TSE:2413 with a GF Score™ of 82/100 and a GF Value™ of 円2,520.72 (Significantly Undervalued). The stock has 3 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

M3's adjusted revenue per share for the three months ended in Mar. 2026 was 円128.423. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is 円303.69 for the trailing ten years ended in Mar. 2026.

During the past 12 months, M3's average Cyclically Adjusted Revenue Growth Rate was 17.00% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was 18.10% per year. During the past 5 years, the average Cyclically Adjusted Revenue Growth Rate was 20.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of M3 was 23.30% per year. The lowest was 18.10% per year. And the median was 22.25% per year.

As of today (2026-08-05), M3's current stock price is 円1735.00. M3's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2026 was 円303.69. M3's Cyclically Adjusted PS Ratio of today is 5.71.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of M3 was 92.80. The lowest was 4.46. And the median was 25.27.


M3  (TSE:2413) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

M3's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=1735.00/303.69
=5.71

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of M3 was 92.80. The lowest was 4.46. And the median was 25.27.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


M3 Cyclically Adjusted Revenue per Share Related Terms


M3 Cyclically Adjusted Revenue per Share Historical Data

* Premium members only.

The historical data trend for M3's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

M3 Cyclically Adjusted Revenue per Share Chart

M3 Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 149.54 184.23 218.16 259.46 303.69

M3 Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 259.46 270.83 281.40 294.70 303.69

TSE:2413 vs VEEV, BTSG, HQY: Cyclically Adjusted Revenue per Share Comparison

For the Health Information Services subindustry, M3's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


M3 Cyclically Adjusted PS Ratio vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, M3's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where M3's Cyclically Adjusted PS Ratio falls into.


TSE:2413
82GF Score
M3 Inc TSE:2413
Cyclically Adjusted Revenue per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

M3 Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, M3's adjusted Revenue per Share data for the three months ended in Mar. 2026 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=128.423/112.7000*112.7000
=128.423

Current CPI (Mar. 2026) = 112.7000.

M3 Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201606 27.868 98.100 32.016
201609 25.953 98.000 29.846
201612 33.068 98.400 37.874
201703 33.708 98.100 38.725
201706 33.757 98.500 38.623
201709 32.369 98.800 36.923
201712 39.674 99.400 44.982
201803 39.977 99.200 45.417
201806 41.499 99.200 47.147
201809 40.694 99.900 45.908
201812 46.909 99.700 53.026
201903 45.328 99.700 51.238
201906 45.325 99.800 51.184
201909 45.340 100.100 51.047
201912 51.253 100.500 57.475
202003 51.062 100.300 57.375
202006 52.238 99.900 58.931
202009 58.216 99.900 65.675
202012 71.726 99.300 81.405
202103 66.892 99.900 75.463
202106 68.306 99.500 77.368
202109 75.430 100.100 84.925
202112 83.196 100.100 93.668
202203 79.476 101.100 88.595
202206 83.905 101.800 92.889
202209 81.877 103.100 89.501
202212 92.057 104.100 99.662
202303 81.939 104.400 88.453
202306 84.478 105.200 90.501
202309 85.953 106.200 91.214
202312 93.307 106.800 98.462
202403 87.848 107.200 92.355
202406 94.475 108.200 98.404
202409 89.028 108.900 92.135
202412 118.360 110.700 120.498
202503 116.867 111.100 118.550
202506 126.897 111.700 128.033
202509 124.775 112.000 125.555
202512 137.829 113.000 137.463
202603 128.423 112.700 128.423

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

What does a Cyclically Adjusted Revenue per Share of 円303.69 mean?
M3 (TSE:2413) has a Cyclically Adjusted Revenue per Share of 円303.69 as of Mar. 2026. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on M3 and its competitors.
Is M3's Cyclically Adjusted Revenue per Share too high?
M3's current Cyclically Adjusted Revenue per Share is 円303.69. Overall, M3 has a GF Score™ of 82/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does M3's Cyclically Adjusted Revenue per Share compare to VEEV and BTSG?
M3's Cyclically Adjusted Revenue per Share of 円303.69 can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Revenue per Share for a Healthcare Providers & Services company?
A good Cyclically Adjusted Revenue per Share depends on the Healthcare Providers & Services industry context. However, Cyclically Adjusted Revenue per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Revenue per Share mean?
A high Cyclically Adjusted Revenue per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on M3 and its competitors. M3's current Cyclically Adjusted Revenue per Share is 円303.69. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is M3 stock overvalued right now?
Based on GuruFocus' analysis, M3 (TSE:2413) is currently considered Significantly Undervalued. The stock's GF Value™ is 円2,520.72, compared to a current price of 円1,735.00 — trading 31.2% below its estimated fair value. The current Cyclically Adjusted Revenue per Share is 円303.69. M3's overall GF Score™ is 82/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Revenue per Share calculated?
Cyclically Adjusted Revenue per Share is calculated from a company's financial statements. For M3 (TSE:2413), the current Cyclically Adjusted Revenue per Share is 円303.69 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is M3 (TSE:2413) Overvalued in 2026?

Based on GuruFocus' analysis, M3 stock appears to be undervalued. The current stock price of 円1,735.00 is trading 31.2% below its estimated GF Value™ of 円2,520.72. GuruFocus considers M3 to be Significantly Undervalued.

Key valuation signals for TSE:2413:

  • Cyclically Adjusted Revenue per Share: 円303.69
  • GF Value™: 円2,520.72 vs. price of 円1,735.00 (31.2% below fair value)
  • GF Score™: 82/100 with 3 warning signs

No single metric tells the full story. See the TSE:2413 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


M3 Business Description

Other Exchanges MTHRY:USA4YC:Germany
Address 1-11-44 Akasaka, Akasaka Intercity, 10th Floor, Minato-ku, Tokyo, JPN, 107-0052
M3 Inc is a Japan-based company engaged in providing medical-related services through internet-based platforms and real-world operations. The company operates six reportable segments: Medical Platform, Evidence Solutions, Career Solutions, Site Solutions, Patient Solutions, and Overseas. Its businesses include online marketing for medical professionals, clinical trial support, human resources services for medical professionals, operational support for medical institutions, and patient support services. The Overseas segment offers similar services internationally, including in the United States, the United Kingdom, China, South Korea, India, France, Germany, and Spain.
82GF Score

Get the complete analysis for TSE:2413

Cyclically Adjusted Revenue per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円1,735.00
Price
円2,520.72
GF Value